JP2023520499A - 色素沈着肌タイプ判断用遺伝子多型マーカー及びその用途 - Google Patents
色素沈着肌タイプ判断用遺伝子多型マーカー及びその用途 Download PDFInfo
- Publication number
- JP2023520499A JP2023520499A JP2022560138A JP2022560138A JP2023520499A JP 2023520499 A JP2023520499 A JP 2023520499A JP 2022560138 A JP2022560138 A JP 2022560138A JP 2022560138 A JP2022560138 A JP 2022560138A JP 2023520499 A JP2023520499 A JP 2023520499A
- Authority
- JP
- Japan
- Prior art keywords
- base
- human chromosome
- dna sequences
- sequences containing
- consecutive dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003550 marker Substances 0.000 title claims abstract description 54
- 230000036555 skin type Effects 0.000 title abstract description 23
- 206010071602 Genetic polymorphism Diseases 0.000 title abstract description 5
- 208000012641 Pigmentation disease Diseases 0.000 claims abstract description 95
- 239000000523 sample Substances 0.000 claims abstract description 27
- 238000000034 method Methods 0.000 claims abstract description 26
- 239000000203 mixture Substances 0.000 claims abstract description 17
- 108091033319 polynucleotide Proteins 0.000 claims description 265
- 239000002157 polynucleotide Substances 0.000 claims description 265
- 102000040430 polynucleotide Human genes 0.000 claims description 265
- 239000002773 nucleotide Substances 0.000 claims description 47
- 125000003729 nucleotide group Chemical group 0.000 claims description 47
- 238000002493 microarray Methods 0.000 claims description 15
- 230000000295 complement effect Effects 0.000 claims description 9
- 238000000018 DNA microarray Methods 0.000 claims description 8
- 230000003321 amplification Effects 0.000 claims description 7
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 7
- 238000003757 reverse transcription PCR Methods 0.000 claims description 4
- 210000003296 saliva Anatomy 0.000 claims description 4
- 238000012790 confirmation Methods 0.000 claims description 3
- 239000008280 blood Substances 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 claims description 2
- 210000001124 body fluid Anatomy 0.000 claims description 2
- 239000010839 body fluid Substances 0.000 claims description 2
- 210000004209 hair Anatomy 0.000 claims description 2
- 210000002700 urine Anatomy 0.000 claims description 2
- 230000019612 pigmentation Effects 0.000 abstract description 27
- 210000003917 human chromosome Anatomy 0.000 description 846
- 108091028043 Nucleic acid sequence Proteins 0.000 description 254
- 108700028369 Alleles Proteins 0.000 description 74
- 210000000349 chromosome Anatomy 0.000 description 38
- 108020004414 DNA Proteins 0.000 description 32
- 238000004458 analytical method Methods 0.000 description 22
- 108090000623 proteins and genes Proteins 0.000 description 20
- 238000009396 hybridization Methods 0.000 description 15
- 150000007523 nucleic acids Chemical group 0.000 description 13
- 230000002068 genetic effect Effects 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 11
- 102000039446 nucleic acids Human genes 0.000 description 10
- 108020004707 nucleic acids Proteins 0.000 description 10
- 230000000694 effects Effects 0.000 description 7
- 230000007423 decrease Effects 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 238000001514 detection method Methods 0.000 description 5
- 239000005546 dideoxynucleotide Substances 0.000 description 5
- 238000012163 sequencing technique Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000012252 genetic analysis Methods 0.000 description 4
- 238000003205 genotyping method Methods 0.000 description 4
- 238000012417 linear regression Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000006467 substitution reaction Methods 0.000 description 4
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 3
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 3
- 101000740482 Homo sapiens Zinc finger protein basonuclin-2 Proteins 0.000 description 3
- 102100034343 Integrase Human genes 0.000 description 3
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 3
- 102100037208 Zinc finger protein basonuclin-2 Human genes 0.000 description 3
- 230000002759 chromosomal effect Effects 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000007614 genetic variation Effects 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000003908 quality control method Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- OAKPWEUQDVLTCN-NKWVEPMBSA-N 2',3'-Dideoxyadenosine-5-triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO[P@@](O)(=O)O[P@](O)(=O)OP(O)(O)=O)O1 OAKPWEUQDVLTCN-NKWVEPMBSA-N 0.000 description 2
- 230000006820 DNA synthesis Effects 0.000 description 2
- 206010064571 Gene mutation Diseases 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 238000007844 allele-specific PCR Methods 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 230000003100 immobilizing effect Effects 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 238000007834 ligase chain reaction Methods 0.000 description 2
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- -1 nucleoside triphosphates Chemical class 0.000 description 2
- 239000011535 reaction buffer Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000001226 triphosphate Substances 0.000 description 2
- 235000011178 triphosphate Nutrition 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 101001011441 Homo sapiens Interferon regulatory factor 4 Proteins 0.000 description 1
- 101000989639 Homo sapiens Major facilitator superfamily domain-containing protein 12 Proteins 0.000 description 1
- 101001134060 Homo sapiens Melanocyte-stimulating hormone receptor Proteins 0.000 description 1
- 101001123325 Homo sapiens Peroxisome proliferator-activated receptor gamma coactivator 1-beta Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 101000829171 Hypocrea virens (strain Gv29-8 / FGSC 10586) Effector TSP1 Proteins 0.000 description 1
- 102100030126 Interferon regulatory factor 4 Human genes 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 102100029281 Major facilitator superfamily domain-containing protein 12 Human genes 0.000 description 1
- 102100034216 Melanocyte-stimulating hormone receptor Human genes 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 102100037258 Membrane-associated transporter protein Human genes 0.000 description 1
- 108091092878 Microsatellite Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102100028961 Peroxisome proliferator-activated receptor gamma coactivator 1-beta Human genes 0.000 description 1
- 102220557616 Peroxisome proliferator-activated receptor gamma coactivator 1-beta_R265Q_mutation Human genes 0.000 description 1
- 102220557615 Peroxisome proliferator-activated receptor gamma coactivator 1-beta_V279I_mutation Human genes 0.000 description 1
- 229920012196 Polyoxymethylene Copolymer Polymers 0.000 description 1
- 108010069820 Pro-Opiomelanocortin Proteins 0.000 description 1
- 102100027467 Pro-opiomelanocortin Human genes 0.000 description 1
- 108091006701 SLC24A5 Proteins 0.000 description 1
- 108091007563 SLC45A2 Proteins 0.000 description 1
- 102100032079 Sodium/potassium/calcium exchanger 5 Human genes 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 1
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 1
- RZCIEJXAILMSQK-JXOAFFINSA-N TTP Chemical compound O=C1NC(=O)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 RZCIEJXAILMSQK-JXOAFFINSA-N 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
- 108010057266 Type A Botulinum Toxins Proteins 0.000 description 1
- 102100040210 UDP-glucuronosyltransferase 1A8 Human genes 0.000 description 1
- 108010074998 UGT1A8 UDP-glucuronosyltransferase Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008236 biological pathway Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 229940089093 botox Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- 230000030609 dephosphorylation Effects 0.000 description 1
- 238000006209 dephosphorylation reaction Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000007937 eating Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000008298 phosphoramidates Chemical class 0.000 description 1
- 150000008300 phosphoramidites Chemical class 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 102220112277 rs2228478 Human genes 0.000 description 1
- 102200068758 rs2228479 Human genes 0.000 description 1
- 102210033012 rs251464 Human genes 0.000 description 1
- 102210056462 rs251468 Human genes 0.000 description 1
- 102220186006 rs3212369 Human genes 0.000 description 1
- 102220171098 rs3212371 Human genes 0.000 description 1
- 102210015312 rs32576 Human genes 0.000 description 1
- 102210008691 rs32579 Human genes 0.000 description 1
- 102200068762 rs33932559 Human genes 0.000 description 1
- 102200067234 rs885479 Human genes 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2020-0039353 | 2020-03-31 | ||
| KR20200039353 | 2020-03-31 | ||
| KR1020200096881A KR20210122017A (ko) | 2020-03-31 | 2020-08-03 | 색소침착 피부 타입 판단용 유전자 다형성 마커 및 이의 용도 |
| KR10-2020-0096881 | 2020-08-03 | ||
| PCT/KR2021/003995 WO2021201592A1 (ko) | 2020-03-31 | 2021-03-31 | 색소침착 피부 타입 판단용 유전자 다형성 마커 및 이의 용도 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2023520499A true JP2023520499A (ja) | 2023-05-17 |
Family
ID=77929689
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022560138A Pending JP2023520499A (ja) | 2020-03-31 | 2021-03-31 | 色素沈着肌タイプ判断用遺伝子多型マーカー及びその用途 |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP2023520499A (zh) |
| CN (1) | CN115362268A (zh) |
| WO (1) | WO2021201592A1 (zh) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101763949B1 (ko) * | 2011-08-03 | 2017-08-03 | 주식회사 엘지생활건강 | 보습 피부 타입 유전자 다형성 마커 및 이의 용도 |
| KR20170124003A (ko) * | 2016-04-29 | 2017-11-09 | (주)아모레퍼시픽 | 피부 색소 침착의 예측 방법 |
| KR102485223B1 (ko) * | 2017-09-29 | 2023-01-05 | (주)아모레퍼시픽 | 피부 색소 침착 예측용 유전자 다형성 마커 및 이의 용도 |
| KR20190071979A (ko) * | 2017-12-15 | 2019-06-25 | 서경대학교 산학협력단 | 피부특성 진단용 프라이머 세트, 조성물 및 키트 그리고 이를 이용한 피부특성 진단 방법 |
| KR102044356B1 (ko) * | 2018-03-27 | 2019-11-13 | (주)메디젠휴먼케어 | 단일염기다형성을 이용한 피부 표현형 예측 방법 |
-
2021
- 2021-03-31 JP JP2022560138A patent/JP2023520499A/ja active Pending
- 2021-03-31 CN CN202180026418.8A patent/CN115362268A/zh active Pending
- 2021-03-31 WO PCT/KR2021/003995 patent/WO2021201592A1/ko active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| CN115362268A (zh) | 2022-11-18 |
| WO2021201592A1 (ko) | 2021-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101768418B1 (ko) | 미백 피부 타입 유전자 다형성 마커 및 이의 용도 | |
| JP5427352B2 (ja) | ヒト体脂肪量と関連する遺伝子多型に基づく肥満発症リスクの判定方法 | |
| JP2023520499A (ja) | 色素沈着肌タイプ判断用遺伝子多型マーカー及びその用途 | |
| KR20220141658A (ko) | 피부색 판단용 유전자 다형성 마커 및 이의 용도 | |
| KR20210122017A (ko) | 색소침착 피부 타입 판단용 유전자 다형성 마커 및 이의 용도 | |
| KR20220141659A (ko) | 피부색 판단용 유전자 다형성 마커 및 이의 용도 | |
| KR20220148555A (ko) | 피부 턴오버 및 각질 과각화 판단용 유전자 다형성 마커 및 이의 용도 | |
| JP2023180556A (ja) | 薄毛の遺伝的素因の判定方法 | |
| KR20220137382A (ko) | 주름 피부 타입 판단용 유전자 다형성 마커 및 이의 용도 | |
| KR20230072018A (ko) | 피부 주름 생성 위험도 예측용 바이오마커 및 이의 용도 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20221003 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240313 |